pirinixic acid has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Archer, DC; Cunard, R; DiCampli, D; Glass, CK; Kelly, CJ; Ricote, M; Stevenson, JL | 1 |
1 other study(ies) available for pirinixic acid and myelin oligodendrocyte glycoprotein (35-55)
Article | Year |
---|---|
WY14,643, a PPAR alpha ligand, has profound effects on immune responses in vivo.
Topics: Administration, Oral; Animals; Antibody Formation; Apoptosis; B-Lymphocyte Subsets; Cell Death; Cytokines; Glycoproteins; Growth Inhibitors; Immunosuppressive Agents; Ligands; Lymphocyte Count; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Peroxisome Proliferators; Peroxisomes; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Spleen; T-Lymphocyte Subsets; Transcription Factors | 2002 |